OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion

被引:261
|
作者
Zanna, Claudia [1 ]
Ghelli, Anna [1 ]
Porcelli, Anna Maria [1 ]
Karbowski, Mariusz [2 ]
Youle, Richard J. [2 ]
Schimpf, Simone [3 ]
Wissinger, Bernd [3 ]
Pinti, Marcello [4 ,5 ]
Cossarizza, Andrea [4 ,5 ]
Vidoni, Sara [1 ]
Valentino, Maria Lucia [6 ]
Rugolo, Michela [1 ]
Carelli, Valerio [6 ]
机构
[1] Univ Bologna, Dipartimento Biol Evoluz Sperimentale, I-40126 Bologna, Italy
[2] NINDS, Biochem Sect, NIH, Bethesda, MD 20892 USA
[3] Univ Eye Hosp, Mol Genet Lab, Tubingen, Germany
[4] Univ Modena, Sezione Patol Gen, Dipartimento Sci Biomed, I-41100 Modena, Italy
[5] Univ Reggio Emilia, Dipartimento Biol Evoluz Sperimentale, Reggio Emilia, Italy
[6] Univ Bologna, Dipartimento Sci Neurol, I-40126 Bologna, Italy
关键词
OPA1; DOA; oxidative phosphorylation; mitochondrial fusion; AIF;
D O I
10.1093/brain/awm335
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dominant optic atrophy ( DOA) is characterized by retinal ganglion cell degeneration leading to optic neuropathy. A subset of DOA is caused by mutations in the OPA1 gene, encoding for a dynamin-related GTPase required for mitochondrial fusion. The functional consequences of OPA1 mutations in DOA patients are still poorly understood. This study investigated the effect of five different OPA1 pathogenic mutations on the energetic efficiency and mitochondrial network dynamics of skin fibroblasts from patients. Although DOA fibroblasts maintained their ATP levels and grew in galactose medium, i.e. under forced oxidative metabolism, a significant impairment in mitochondrial ATP synthesis driven by complex I substrates was found. Furthermore, balloon-like structures in the mitochondrial reticulum were observed in galactose medium and mitochondrial fusion was completely inhibited in about 50% of DOA fibroblasts, but not in control cells. Respiratory complex assembly and the expression level of complex I subunits were similar in control and DOA fibroblasts. Co-immunoprecipitation experiments revealed that OPA1 directly interacts with subunits of complexes I, II and III, but not IV and with apoptosis inducing factor. The results disclose a novel link between OPA1, apoptosis inducing factor and the respiratory complexes that may shed some light on the pathogenic mechanism of DOA.
引用
收藏
页码:352 / 367
页数:16
相关论文
共 26 条
  • [1] Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics
    Marcel V Alavi
    Nico Fuhrmann
    Molecular Neurodegeneration, 8
  • [2] Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics
    Alavi, Marcel V.
    Fuhrmann, Nico
    MOLECULAR NEURODEGENERATION, 2013, 8
  • [3] Validation of a MGM1/OPA1 chimeric gene for functional analysis in yeast of mutations associated with dominant optic atrophy
    Nolli, Cecilia
    Goffrini, Paola
    Lazzaretti, Mirca
    Zanna, Claudia
    Vitale, Rita
    Lodi, Tiziana
    Baruffini, Enrico
    MITOCHONDRION, 2015, 25 : 38 - 48
  • [4] Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opal gene
    Formichi, Patrizia
    Radi, Elena
    Giorgi, Eleonora
    Gallus, Gian Nicola
    Brunetti, Jlenia
    Battisti, Carla
    Rufa, Alessandra
    Dotti, Maria Teresa
    Franceschini, Rossella
    Bracci, Luisa
    Federico, Antonio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 351 (1-2) : 99 - 108
  • [5] OPA1 Deficiency Associated with Increased Autophagy in Retinal Ganglion Cells in a Murine Model of Dominant Optic Atrophy
    White, Kathryn E.
    Davies, Vanessa J.
    Hogan, Vanessa E.
    Piechota, Malgorzata J.
    Nichols, Philip P.
    Turnbull, Douglas M.
    Votruba, Marcela
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (06) : 2567 - 2571
  • [6] Loss of functional OPA1 unbalances redox state: implications in dominant optic atrophy pathogenesis
    Millet, Aurelie M. C.
    Bertholet, Ambre M.
    Daloyau, Marlene
    Reynier, Pascal
    Galinier, Anne
    Devin, Anne
    Wissinguer, Bernd
    Belenguer, Pascale
    Davezac, Noelie
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (06): : 408 - 421
  • [7] Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct OPA1 mutations and clinical pathologies
    Pohl, Katherine A.
    Zhang, Xiangmei
    Pham, Anh H.
    Chan, Jane W.
    Sadun, Alfredo A.
    Yang, Xian-Jie
    FRONTIERS IN GENETICS, 2023, 14
  • [8] Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells
    Sladen, Paul E.
    Jovanovic, Katarina
    Guarascio, Rosellina
    Ottaviani, Daniele
    Salsbury, Grace
    Novoselova, Tatiana
    Chapple, J. Paul
    Yu-Wai-Man, Patrick
    Cheetham, Michael E.
    HUMAN MOLECULAR GENETICS, 2022, 31 (20) : 3478 - 3493
  • [9] Targeting OPA1 protein for therapeutic intervention in autosomal dominant optic atrophy: In silico drug discovery
    Iqbal, Azhar
    Sajid, Muhammad
    Abdelkrim, Guendouzi
    Riaz, Ammara
    Farooq, Umar
    Bibi, Shabana
    Albadrani, Ghadeer M.
    Al-Ghadi, Muath Q.
    Sayed, Amany A.
    Abdel-Daim, Mohamed M.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2025, 138
  • [10] Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy
    Williams, Pete A.
    Morgan, James E.
    Votruba, Marcela
    BRAIN, 2010, 133 : 2942 - 2951